{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:49:20Z","timestamp":1788306560764,"version":"build-2803163510"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T00:00:00Z","timestamp":1494633600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s40620-017-0408-8","type":"journal-article","created":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T10:28:24Z","timestamp":1494671304000},"page":"663-670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Circulating markers of bone turnover"],"prefix":"10.1093","volume":"30","author":[{"name":"on behalf of CKD-MBD working group of ERA-EDTA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc G.","family":"Vervloet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent M.","family":"Brandenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,5,13]]},"reference":[{"issue":"2467","key":"408_CR1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1126\/science.95.2467.388","volume":"95","author":"SH Liu","year":"1942","unstructured":"Liu SH, Chu HI (1942) Treatment of renal osteodystrophy with dihydrotachysterol (A.T.10) and iron. Science 95(2467):388\u2013389","journal-title":"Science"},{"issue":"11","key":"408_CR2","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 69(11):1945\u20131953","journal-title":"Kidney Int"},{"issue":"9","key":"408_CR3","first-page":"2294","volume":"13","author":"G Coen","year":"1998","unstructured":"Coen G, Ballanti P, Bonucci E, Calabria S, Centorrino M, Fassino V et al (1998) Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Ren Assoc 13(9):2294\u20132302","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Ren Assoc"},{"issue":"Suppl 3","key":"408_CR4","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.2215\/CJN.04301206","volume":"3","author":"SM Ott","year":"2008","unstructured":"Ott SM (2008) Histomorphometric measurements of bone turnover, mineralization, and volume. Clin J Am Soc Nephrol 3(Suppl 3):S151\u2013S156","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"408_CR5","first-page":"317","volume":"22","author":"R Koos","year":"2013","unstructured":"Koos R, Brandenburg V, Mahnken AH, Schneider R, Dohmen G, Autschbach R et al (2013) Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study. J Heart Valve Dis 22(3):317\u2013325","journal-title":"J Heart Valve Dis"},{"issue":"5","key":"408_CR6","doi-asserted-by":"crossref","first-page":"e19595","DOI":"10.1371\/journal.pone.0019595","volume":"6","author":"D Zhu","year":"2011","unstructured":"Zhu D, Mackenzie NC, Millan JL, Farquharson C, MacRae VE (2011) The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PLoS One 6(5):e19595","journal-title":"PLoS One"},{"issue":"2","key":"408_CR7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000346161","volume":"50","author":"M Haarhaus","year":"2013","unstructured":"Haarhaus M, Arnqvist HJ, Magnusson P (2013) Calcifying human aortic smooth muscle cells express different bone alkaline phosphatase isoforms, including the novel B1x isoform. J Vasc Res 50(2):167\u2013174","journal-title":"J Vasc Res"},{"issue":"5","key":"408_CR8","first-page":"997","volume":"29","author":"P Delanaye","year":"2014","unstructured":"Delanaye P, Souberbielle JC, Lafage-Proust MH, Jean G, Cavalier E (2014) Can we use circulating biomarkers to monitor bone turnover in CKD haemodialysis patients? Hypotheses and facts. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Ren Assoc 29(5):997\u20131004","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Ren Assoc"},{"key":"408_CR9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cca.2012.12.009","volume":"417","author":"P Delanaye","year":"2013","unstructured":"Delanaye P, Dubois BE, Jouret F, Krzesinski JM, Moranne O, Cavalier E (2013) Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients: is it so simple? Clin Chim Acta 417:35\u201338","journal-title":"Clin Chim Acta"},{"issue":"6","key":"408_CR10","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","volume":"90","author":"P Evenepoel","year":"2016","unstructured":"Evenepoel P, Bover J, Urena Torres P (2016) Parathyroid hormone metabolism and signaling in health and chronic kidney disease. Kidney Int 90(6):1184\u20131190","journal-title":"Kidney Int"},{"issue":"1","key":"408_CR11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/8756-3282(92)90360-9","volume":"13","author":"P Christiansen","year":"1992","unstructured":"Christiansen P, Steiniche T, Vesterby A, Mosekilde L, Hessov I, Melsen F (1992) Primary hyperparathyroidism: iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods. Bone 13(1):41\u201349","journal-title":"Bone"},{"issue":"9","key":"408_CR12","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/BF03349795","volume":"18","author":"R Rosso","year":"1995","unstructured":"Rosso R, Minisola S, Scarda A, Pacitti MT, Carnevale V, Romagnoli E et al (1995) Temporal relationship between bone loss and increased bone turnover: a longitudinal study following natural menopause. J Endocrinol Invest 18(9):723\u2013728","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"408_CR13","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1210\/jcem-69-6-1160","volume":"69","author":"PJ Kelly","year":"1989","unstructured":"Kelly PJ, Pocock NA, Sambrook PN, Eisman JA (1989) Age and menopause-related changes in indices of bone turnover. J Clin Endocrinol Metab 69(6):1160\u20131165","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"408_CR14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2036.1998.00321.x","volume":"12","author":"G D\u2019Haens","year":"1998","unstructured":"D\u2019Haens G, Verstraete A, Cheyns K, Aerden I, Bouillon R, Rutgeerts P (1998) Bone turnover during short-term therapy with methylprednisolone or budesonide in Crohn\u2019s disease. Aliment Pharmacol Ther 12(5):419\u2013424","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"408_CR15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF03349848","volume":"19","author":"A Conti","year":"1996","unstructured":"Conti A, Sartorio A, Ferrero S, Ferrario S, Ambrosi B (1996) Modifications of biochemical markers of bone and collagen turnover during corticosteroid therapy. J Endocrinol Invest 19(2):127\u2013130","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"408_CR16","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/ki.2014.349","volume":"87","author":"GJ Behets","year":"2015","unstructured":"Behets GJ, Spasovski G, Sterling LR, Goodman WG, Spiegel DM, De Broe ME et al (2015) Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism. Kidney Int 87(4):846\u2013856","journal-title":"Kidney Int"},{"issue":"5","key":"408_CR17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S8756-3282(00)00260-X","volume":"26","author":"T Steiniche","year":"2000","unstructured":"Steiniche T, Christiansen P, Vesterby A, Ullerup R, Hessov I, Mosekilde LE et al (2000) Primary hyperparathyroidism: bone structure, balance, and remodeling before and 3\u00a0years after surgical treatment. Bone 26(5):535\u2013543","journal-title":"Bone"},{"issue":"2","key":"408_CR18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/clinchem\/48.2.220","volume":"48","author":"HW Vesper","year":"2002","unstructured":"Vesper HW, Demers LM, Eastell R, Garnero P, Kleerekoper M, Robins SP et al (2002) Assessment and recommendations on factors contributing to preanalytical variability of urinary pyridinoline and deoxypyridinoline. Clin Chem 48(2):220\u2013235","journal-title":"Clin Chem"},{"issue":"3","key":"408_CR19","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00198-014-2954-4","volume":"26","author":"Y Nagata","year":"2015","unstructured":"Nagata Y, Inaba M, Imanishi Y, Okazaki H, Yamada S, Mori K et al (2015) Increased undercarboxylated osteocalcin\/intact osteocalcin ratio in patients undergoing hemodialysis. Osteoporos Int 26(3):1053\u20131061","journal-title":"Osteoporos Int"},{"key":"408_CR20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12929-015-0183-6","volume":"22","author":"M Zhang","year":"2015","unstructured":"Zhang M, Ni Z, Zhou W, Qian J (2015) Undercarboxylated osteocalcin as a biomarker of subclinical atherosclerosis in non-dialysis patients with chronic kidney disease. J Biomed Sci 22:75","journal-title":"J Biomed Sci"},{"issue":"6","key":"408_CR21","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jgs.12791","volume":"62","author":"K Amrein","year":"2014","unstructured":"Amrein K, Dobnig H, Wagner D, Piswanger-Solkner C, Pieber TR, Pilz S et al (2014) Sclerostin in institutionalized elderly women: associations with quantitative bone ultrasound, bone turnover, fractures, and mortality. J Am Geriatr Soc 62(6):1023\u20131029","journal-title":"J Am Geriatr Soc"},{"key":"408_CR22","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/boneres.2015.5","volume":"3","author":"MS Rahman","year":"2015","unstructured":"Rahman MS, Akhtar N, Jamil HM, Banik RS, Asaduzzaman SM (2015) TGF-beta\/BMP signaling and other molecular events: regulation of osteoblastogenesis and bone formation. Bone Res 3:15005","journal-title":"Bone Res"},{"issue":"10","key":"408_CR23","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1210\/jc.2011-3361","volume":"97","author":"MS Ardawi","year":"2012","unstructured":"Ardawi MS, Rouzi AA, Qari MH (2012) Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: a cross-sectional and a longitudinal study. J Clin Endocrinol Metab 97(10):3691\u20133699","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"408_CR24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0167-4943(97)00032-0","volume":"26","author":"R Ricciotti","year":"1998","unstructured":"Ricciotti R, Gemini R, Foschi F, Dubbini S, Fattoretti P, Bertoni-Freddari C (1998) Physical activity and biochemical markers of bone turnover in elderly patients. Arch Gerontol Geriatr 26(1):49\u201353","journal-title":"Arch Gerontol Geriatr"},{"issue":"113","key":"408_CR25","first-page":"S1","volume":"Supplement","author":"Kidney Disease: Improving Global Outcomes CKDMBDWG","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes CKDMBDWG (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Supplement(113):S1\u2013S130","journal-title":"Kidney Int"},{"issue":"9","key":"408_CR26","first-page":"1542","volume":"30","author":"JL Fernandez-Martin","year":"2015","unstructured":"Fernandez-Martin JL, Martinez-Camblor P, Dionisi MP, Floege J, Ketteler M, London G et al (2015) Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Ren Assoc 30(9):1542\u20131551","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Ren Assoc"},{"issue":"4","key":"408_CR27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","volume":"67","author":"SM Sprague","year":"2016","unstructured":"Sprague SM, Bellorin-Font E, Jorgetti V, Carvalho AB, Malluche HH, Ferreira A et al (2016) Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis. Am J Kidney Dis 67(4):559\u2013566","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"408_CR28","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.1995.201","volume":"47","author":"A Torres","year":"1995","unstructured":"Torres A, Lorenzo V, Hernandez D, Rodriguez JC, Concepcion MT, Rodriguez AP et al (1995) Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Kidney Int 47(5):1434\u20131442","journal-title":"Kidney Int"},{"issue":"5","key":"408_CR29","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/0272-6386(95)90453-0","volume":"26","author":"M Wang","year":"1995","unstructured":"Wang M, Hercz G, Sherrard DJ, Maloney NA, Segre GV, Pei Y (1995) Relationship between intact 1\u201384 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis 26(5):836\u2013844","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"408_CR30","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.2215\/CJN.01770408","volume":"4","author":"C Moore","year":"2009","unstructured":"Moore C, Yee J, Malluche H, Rao DS, Monier-Faugere MC, Adams E et al (2009) Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients. Clin J Am Soc Nephrol 4(9):1484\u20131493","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"408_CR31","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1523-1755.2003.00129.x","volume":"64","author":"BP Sawaya","year":"2003","unstructured":"Sawaya BP, Butros R, Naqvi S, Geng Z, Mawad H, Friedler R et al (2003) Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease. Kidney Int 64(2):737\u2013742","journal-title":"Kidney Int"},{"issue":"6","key":"408_CR32","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1210\/jc.2009-1909","volume":"95","author":"K Wesseling-Perry","year":"2010","unstructured":"Wesseling-Perry K, Harkins GC, Wang HJ, Elashoff R, Gales B, Horwitz MJ et al (2010) The calcemic response to continuous parathyroid hormone (PTH) (1\u201334) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH (7\u201384). J Clin Endocrinol Metab 95(6):2772\u20132780","journal-title":"J Clin Endocrinol Metab"},{"key":"408_CR33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/2050-6511-14-60","volume":"14","author":"YH Kim","year":"2013","unstructured":"Kim YH, Kwak KA, Gil HW, Song HY, Hong SY (2013) Indoxyl sulfate promotes apoptosis in cultured osteoblast cells. BMC Pharmacol Toxicol 14:60","journal-title":"BMC Pharmacol Toxicol"},{"issue":"1","key":"408_CR34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.kint.2016.01.024","volume":"90","author":"N Carrillo-Lopez","year":"2016","unstructured":"Carrillo-Lopez N, Panizo S, Alonso-Montes C, Roman-Garcia P, Rodriguez I, Martinez-Salgado C et al (2016) Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease. Kidney Int 90(1):77\u201389","journal-title":"Kidney Int"},{"issue":"5","key":"408_CR35","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1046\/j.1523-1755.2001.00011.x","volume":"60","author":"ZS Xiao","year":"2001","unstructured":"Xiao ZS, Quarles LD, Chen QQ, Yu YH, Qu XP, Jiang CH et al (2001) Effect of asymmetric dimethylarginine on osteoblastic differentiation. Kidney Int 60(5):1699\u20131704","journal-title":"Kidney Int"},{"issue":"3","key":"408_CR36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.ki.5002035","volume":"71","author":"S Disthabanchong","year":"2007","unstructured":"Disthabanchong S, Radinahamed P, Stitchantrakul W, Hongeng S, Rajatanavin R (2007) Chronic metabolic acidosis alters osteoblast differentiation from human mesenchymal stem cells. Kidney Int 71(3):201\u2013209","journal-title":"Kidney Int"},{"issue":"1","key":"408_CR37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11914-013-0183-y","volume":"12","author":"R Baum","year":"2014","unstructured":"Baum R, Gravallese EM (2014) Impact of inflammation on the osteoblast in rheumatic diseases. Curr Osteoporos Rep 12(1):9\u201316","journal-title":"Curr Osteoporos Rep"},{"issue":"6","key":"408_CR38","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","volume":"26","author":"HH Malluche","year":"2011","unstructured":"Malluche HH, Mawad HW, Monier-Faugere MC (2011) Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res 26(6):1368\u20131376","journal-title":"J Bone Miner Res"},{"issue":"1","key":"408_CR39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1523-1755.2001.00794.x","volume":"60","author":"P Magnusson","year":"2001","unstructured":"Magnusson P, Sharp CA, Magnusson M, Risteli J, Davie MW, Larsson L (2001) Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Kidney Int 60(1):257\u2013265","journal-title":"Kidney Int"},{"issue":"4","key":"408_CR40","doi-asserted-by":"crossref","first-page":"R1365","DOI":"10.1152\/ajpregu.2000.279.4.R1365","volume":"279","author":"KA Johnson","year":"2000","unstructured":"Johnson KA, Hessle L, Vaingankar S, Wennberg C, Mauro S, Narisawa S et al (2000) Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1. Am J Physiol Regul Integr Comp Physiol 279(4):R1365\u2013R1377","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"408_CR41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.ajkd.2015.02.323","volume":"66","author":"M Haarhaus","year":"2015","unstructured":"Haarhaus M, Monier-Faugere MC, Magnusson P, Malluche HH (2015) Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study. Am J Kidney Dis 66(1):99\u2013105","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"408_CR42","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2215\/CJN.10091110","volume":"6","author":"C Drechsler","year":"2011","unstructured":"Drechsler C, Verduijn M, Pilz S, Krediet RT, Dekker FW, Wanner C et al (2011) Bone alkaline phosphatase and mortality in dialysis patients. Clin J Am Soc Nephrol 6(7):1752\u20131759","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"408_CR43","first-page":"1532","volume":"29","author":"Y Maruyama","year":"2014","unstructured":"Maruyama Y, Taniguchi M, Kazama JJ, Yokoyama K, Hosoya T, Yokoo T et al (2014) A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Ren Assoc 29(8):1532\u20131538","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Ren Assoc"},{"issue":"7","key":"408_CR44","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1210\/jc.2010-2878","volume":"96","author":"C Robinson-Cohen","year":"2011","unstructured":"Robinson-Cohen C, Katz R, Hoofnagle AN, Cauley JA, Furberg CD, Robbins JA et al (2011) Mineral metabolism markers and the long-term risk of hip fracture: the cardiovascular health study. J Clin Endocrinol Metab 96(7):2186\u20132193","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"408_CR45","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00268-002-6433-2","volume":"26","author":"E Nordenstrom","year":"2002","unstructured":"Nordenstrom E, Westerdahl J, Lindergard B, Lindblom P, Bergenfelz A (2002) Multifactorial risk profile for bone fractures in primary hyperparathyroidism. World J Surg 26(12):1463\u20131467","journal-title":"World J Surg"},{"issue":"3","key":"408_CR46","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","volume":"7","author":"P Urena","year":"1996","unstructured":"Urena P, Hruby M, Ferreira A, Ang KS, de Vernejoul MC (1996) Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. J Am Soc Nephrol 7(3):506\u2013512","journal-title":"J Am Soc Nephrol"},{"key":"408_CR47","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/bonekey.2015.112","volume":"4","author":"EA Zimmermann","year":"2015","unstructured":"Zimmermann EA, Busse B, Ritchie RO (2015) The fracture mechanics of human bone: influence of disease and treatment. Bonekey Rep 4:743","journal-title":"Bonekey Rep"},{"key":"408_CR48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1479-5876-11-201","volume":"11","author":"G Wheater","year":"2013","unstructured":"Wheater G, Elshahaly M, Tuck SP, Datta HK, van Laar JM (2013) The clinical utility of bone marker measurements in osteoporosis. J Transl Med 11:201","journal-title":"J Transl Med"},{"issue":"4","key":"408_CR49","first-page":"237","volume":"35","author":"SD Vasikaran","year":"2014","unstructured":"Vasikaran SD, Chubb SP, Ebeling PR, Jenkins N, Jones GR, Kotowicz MA et al (2014) Harmonised Australian reference intervals for serum PINP and CTX in adults. Clin Biochem Rev 35(4):237\u2013242","journal-title":"Clin Biochem Rev"},{"issue":"4","key":"408_CR50","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1359\/jbmr.090203","volume":"24","author":"S Baim","year":"2009","unstructured":"Baim S, Miller PD (2009) Assessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw. J Bone Miner Res 24(4):561\u2013574","journal-title":"J Bone Miner Res"},{"issue":"10","key":"408_CR51","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1359\/jbmr.2003.18.10.1912","volume":"18","author":"G Andersson","year":"2003","unstructured":"Andersson G, Ek-Rylander B, Hollberg K, Ljusberg-Sjolander J, Lang P, Norgard M et al (2003) TRACP as an osteopontin phosphatase. J Bone Miner Res 18(10):1912\u20131915","journal-title":"J Bone Miner Res"},{"issue":"4","key":"408_CR52","first-page":"97","volume":"26","author":"MJ Seibel","year":"2005","unstructured":"Seibel MJ (2005) Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev 26(4):97\u2013122","journal-title":"Clin Biochem Rev"},{"issue":"1","key":"408_CR53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3892\/etm.2014.2071","volume":"9","author":"Y Lv","year":"2015","unstructured":"Lv Y, Wang G, Xu W, Tao P, Lv X, Wang Y (2015) Tartrate-resistant acid phosphatase 5b is a marker of osteoclast number and volume in RAW 264.7 cells treated with receptor-activated nuclear kappaB ligand. Exp Ther Med 9(1):143\u2013146","journal-title":"Exp Ther Med"},{"issue":"2","key":"408_CR54","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.2008.03187.x","volume":"69","author":"S Yamada","year":"2008","unstructured":"Yamada S, Inaba M, Kurajoh M, Shidara K, Imanishi Y, Ishimura E et al (2008) Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction. Clin Endocrinol (Oxf) 69(2):189\u2013196","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"408_CR55","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00223-008-9127-4","volume":"82","author":"K Shidara","year":"2008","unstructured":"Shidara K, Inaba M, Okuno S, Yamada S, Kumeda Y, Imanishi Y et al (2008) Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients. Calcif Tissue Int 82(4):278\u2013287","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"408_CR56","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/cen.12070","volume":"78","author":"S Yamada","year":"2013","unstructured":"Yamada S, Tsuruya K, Yoshida H, Taniguchi M, Haruyama N, Tanaka S et al (2013) The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis. Clin Endocrinol (Oxf) 78(6):844\u2013851","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-017-0408-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-017-0408-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-017-0408-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:59Z","timestamp":1777564619000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/30\/5\/663\/8371263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,13]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1007\/s40620-017-0408-8","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,13]]}}}